Shastri Vivek M, Schmidt Kristina H
Department of Cell Biology, Microbiology and Molecular BiologyUniversity of South FloridaTampaFlorida33620; Graduate Program in Cell and Molecular BiologyUniversity of South FloridaTampaFlorida33620.
Department of Cell Biology, Microbiology and Molecular BiologyUniversity of South FloridaTampaFlorida33620; Cancer Biology and Evolution ProgramH. Lee Moffitt Cancer Center and Research InstituteTampaFlorida33612.
Mol Genet Genomic Med. 2015 Nov 26;4(1):106-19. doi: 10.1002/mgg3.188. eCollection 2016 Jan.
Bloom syndrome is an autosomal recessive disorder characterized by extraordinary cancer incidence early in life and an average life expectancy of ~27 years. Premature stop codons in BLM, which encodes a DNA helicase that functions in DNA double-strand-break repair, make up the vast majority of Bloom syndrome mutations, with only 13 single amino acid changes identified in the syndrome. Sequencing projects have identified nearly one hundred single nucleotide variants in BLM that cause amino acid changes of uncertain significance.
Here, in addition to identifying five BLM variants incapable of complementing certain defects of Bloom syndrome cells, making them candidates for new Bloom syndrome causing mutations, we characterize a new class of BLM variants that cause some, but not all, cellular defects of Bloom syndrome. We find elevated sister-chromatid exchanges, a delayed DNA damage response and inefficient DNA repair. Conversely, hydroxyurea sensitivity and quadriradial chromosome accumulation, both characteristic of Bloom syndrome cells, are absent. These intermediate variants affect sites in BLM that function in ATP hydrolysis and in contacting double-stranded DNA.
Allele frequency and cellular defects suggest candidates for new Bloom syndrome causing mutations, and intermediate BLM variants that are hypomorphic which, instead of causing Bloom syndrome, may increase a person's risk for cancer or possibly other Bloom-syndrome-associated disorders, such as type-2 diabetes.
布卢姆综合征是一种常染色体隐性疾病,其特征是在生命早期癌症发病率极高,平均预期寿命约为27岁。BLM基因中的过早终止密码子构成了布卢姆综合征突变的绝大部分,该基因编码一种在DNA双链断裂修复中起作用的DNA解旋酶,在该综合征中仅发现13种单氨基酸变化。测序项目已在BLM基因中鉴定出近100个导致氨基酸变化但意义不明的单核苷酸变体。
在此,我们除了鉴定出5种无法弥补布卢姆综合征细胞某些缺陷的BLM变体,使其成为新的布卢姆综合征致病突变候选者外,还对一类新的BLM变体进行了表征,这类变体导致了布卢姆综合征的部分而非全部细胞缺陷。我们发现姐妹染色单体交换增加、DNA损伤反应延迟以及DNA修复效率低下。相反,布卢姆综合征细胞特有的羟基脲敏感性和四射体染色体积累则不存在。这些中间变体影响BLM基因中在ATP水解和与双链DNA接触中起作用的位点。
等位基因频率和细胞缺陷提示了新的布卢姆综合征致病突变候选者,以及功能减退的中间BLM变体,这些变体不会导致布卢姆综合征,反而可能增加个体患癌症或其他可能与布卢姆综合征相关疾病(如2型糖尿病)的风险。